ARCHIVES

New CIDAC RFP Limits Recompetition To Small Business Firms

This article is from The Cancer Letter archive.

Vol. 10 No. 01 | January 6, 1984

Download PDF Visit The Full Archive

Related Articles

LabCorp Marketing Of Ovarian Cancer Test Unlawful, FDA Says In Warning Letter.

October 17, 2008

Steven Curley Named Chief of Surgical Oncology At Baylor’s Dan L. Duncan Cancer Center

October 4, 2013

Taxol Recommended For Second Line Therapy In Platinum-Resistant Metastatic Ovarian Cancer

November 20, 1992

AGS-003 Immunotherapy Induces T Cell Responses in Phase II Trial

November 29, 2013

GAO Finds Little Wrong With Drug Testing Program, But Offers Some Suggestions Anyways

July 1, 1983

Women’s Health: Treatment to Move Toward Pre-Cancer, Klausner Says

December 5, 1997